Novotech recently announced that it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials which is an affiliate of international healthcare company, Sonic Healthcare.

This partnership will enable Novotech clients to select from a wide menu of assays or biomarkers, access a trial-specific kit assembly service and use a single clinical trial-dedicated laboratory with a global reach, for priority processing of clinical trial samples. 

Announcing the new partnership, Dr. John Moller, CEO, Novotech said “Novotech has always focused on offering flexible and cost effective clinical trial solutions. Through our partnership with Sonic Clinical Trials, our clients will experience a seamless integration of laboratory services and clinical trial data management by Novotech. From the start to finish, our clients are supported by a team of dedicated project managers.”

“Another key benefit to our clients is the fact that Sonic Clinical Trials is pre-audited and an approved Novotech vendor. This removes our clients’ need to undertake their own central lab vendor assurance providing a further savings in cost and clinical trial time. Novotech’s size and Asia Pacific focus allows our clients to enjoy a direct, hands-on approach to accessing some of the largest patient pools in the world but we balance this with providing global gold-standard central laboratory services and data management platforms.” he added